Reviva Pharmaceuticals
RVPH
RVPH
31 hedge funds and large institutions have $8.75M invested in Reviva Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
9
Increased
12
Reduced
4
Closed
5
Calls
$492K
Puts
$176K
Net Calls
+$316K
Net Calls Change
-$1.16M
Top Buyers
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$688K |
| 2 |
Millennium Management
New York
|
+$495K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$303K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$240K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$159K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$258K |
| 2 |
JPMorgan Chase & Co
New York
|
-$146K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$132K |
| 4 |
Jane Street
New York
|
-$114K |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
-$52.9K |
